Source link : https://newshealth.biz/health-news/colchicine-for-cv-reduction-splits-cardiologists/
While conducting the CLEAR SYNERGY (OASIS 9) trial, lead author Sanjit Jolly, MD continued to treat some of his patients with post–myocardial infarction (MI), including his late father, with colchicine. Then the trial showed that the anti-inflammatory drug was no better than placebo for the composite outcome. “We believed it would work,” Jolly, of McMaster […]
The post Colchicine for CV Reduction Splits Cardiologists first appeared on News Health.
Author : News Health
Publish date : 2025-03-12 12:47:00
Copyright for syndicated content belongs to the linked Source.